The Company, under the leadership of its new CEO, Diede van den Ouden, who joined in the June 2025, is currently undertaking a strategic restructuring with the goal of providing the financial ...
Aptamer Group Plc ( ($GB:APTA) ) has provided an update. Aptamer Group has secured a significant new contract with a top five pharmaceutical ...
Optimer binders against three therapeutic targets to support drug validation and potential clinical trial applications ...
News-Medical.Net on MSN
Top-five pharmaceutical company expands partnership with Aptamer for multi-target Optimer® development program
Aptamer Group plc, the developer of next-generation synthetic binders for the life sciences industry, today announced a new ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback